7-Chlorokynurenic acid 1 is a potent glycine-N-methyl-D-aspartate (NMDA) receptor antagunist, but it shows weak activity after systemic administration. In order to overcome the Blood-brain barrier (BBB), we synthetized three new esters 2-4 of 1 obtained by chemical conjugation with essential nutrients such as glucose and galactose, that are actively transported across the BBB. These compounds were assayed to evaluate their in vitro chemical and enzymatic hydrolysis. In addition the prodrugs 2-4 were tested for their ability to protect mice against NMDA-induced seizures after systemic administration. All the prodrugs 2-4 appeared moderately stable in pH 7.4 buffered solution and were susceptible to in vitro enzymatic hydrolysis. Intraperitoneal administration of either esters 2 or 4 was highly protective against seizures induced by NMDA in mice, with the latter prodrug showing the highest anticonvulsive activity. In addition, ester 4 undergoes a time-dependent extracellular hydrolysis into 1 when applied to mixed cultures of mouse cortical cells, a model that reproduces in vitro the cellular milieu encountered by the prodrugs once they penetrate the blain parenchyma. (C) 2000 Published by Elsevier Science B.V. All rights reserved.
|Titolo:||Synthesis, pharmacokinetics and anticonvulsant activity of 7-chlorokynurenic acid prodrugs|
|Autori interni:||BONINA, Francesco Paolo|
|Data di pubblicazione:||2000|
|Rivista:||INTERNATIONAL JOURNAL OF PHARMACEUTICS|
|Appare nelle tipologie:||1.1 Articolo in rivista|